William F. Feehery is the Chief Executive Officer at Certara, Inc., a leading provider of biosimulation software and technology-enabled services to pharmaceutical and biotechnology companies. With a robust background in the life sciences industry, Feehery has played a pivotal role in steering Certara towards significant growth and innovation. Before joining Certara, he held various leadership positions at companies such as Johnson & Johnson and ICON plc, where he honed his expertise in strategic planning, operational management, and business development. At Certara, Feehery has been instrumental in expanding the company's portfolio of solutions and services, which are critical in drug development and regulatory processes. Under his leadership, Certara has successfully integrated advanced technologies such as artificial intelligence and machine learning to enhance its biosimulation capabilities, thereby improving the efficiency and effectiveness of drug discovery and development. His strategic vision has also led to several key acquisitions that have strengthened Certara's market position and broadened its global reach. Feehery's achievements extend beyond corporate success; he is also recognized for his commitment to fostering a culture of innovation and excellence within Certara. He has been a proponent of collaborative research initiatives and partnerships with academic institutions and other industry players, which have further solidified Certara's reputation as a leader in the biosimulation field. As CEO, Feehery continues to drive the company's mission to transform traditional drug development into a more predictive, efficient, and successful process.